The Board of Directors of JMI Syringes & Medical Devices Limited, a listed company, has taken an important decision in its 243rd meeting held on March 3, 2025. The meeting approved the revaluation of the company’s property, plant and equipment (land and factory buildings) as on December 31, 2024.
The revaluation was carried out by renowned chartered accountancy firm Malek Siddiqui Wali and Valuers, where the replacement cost/current method for buildings and the current market value method for land were followed.
Furthermore, this decision and the financial indicators of the company have been published in accordance with the guidelines of the appropriate regulatory authorities, which can ensure the future financial growth of the company.
